Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified Health Condition 2: M150- Primary generalized (osteo)arthritis Health Condition 3: M255- Pain in joint Health Condition 4: M479- Spondylosis, unspecified Health Condition 5: M659- Synovitis and tenosynovitis, unspecified Health Condition 6: M629- Disorder of muscle, unspecified Health Condition 7: M715- Other bursitis, not elsewhere classified Health Condition 8: M109- Gout, unspecified Health Condition 9: M138- O
Conditions
Interventions
Intervention1: and other Homoeopathic medicines: Rhus toxicodendron and other Homoeopathic medicines in
centesimal potencies shall be
used in the trial.
The dose of the medicine will be
given as per
Sponsors
Central council for research in Homoeopathy
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age between 18-70 years 2. Both sexes 3. Patients are suffering from any type of Musculoskeletal Disorders (Diagnosis is based clinically and physical examination; with or without imaging or other evidences). 4. Patients willing to give written consent for participation in the study. 5. Patients with controlled metabolic and systemic diseases. 6. Wash-out period of at least two weeks for any ongoing conventional medicines
Exclusion criteria
Exclusion criteria: 1. Unwillingness of Patients to participate or to comply with the study requirements. 2. Pregnant women or lactating mother 3. Psychiatric illness 4. Self reported immunocompromised state, 5. Drug or substance abuse or dependence. • Other uncontrolled or advanced pulmonary Diabetes mellitus, systemic diseases or pathologies affecting quality of life.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Likelihood ratio of four symptoms of Rhus toxicodendron as mentioned will be estimated as per the patient-rated outcomes through ORIDL Scales and MYMOP-2.Timepoint: at base line, after 6 months of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Evaluate the positive responses of Homoeopathic intervention in patient with Musculoskeletal disorders using ORIDL score & MYMOP2 score 2. Assessment of the pain intensity by NRS in patients with Musculoskeletal disorders. 3. Validate the four (4) characteristic symptoms of Rhus toxicodendron as mentioned Timepoint: baseline, monthly for 6 months | — |
Countries
India
Contacts
Public ContactDr Suraia Parveen
Dr Anjali Chatterji Regional Research Institute for Homoeopathy
Outcome results
None listed